Atlas Trials

Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction (METHOD)

Clinical trial NCT05210465 · COMPLETED

Trial details

NCT number
NCT05210465
Sponsor
Servier Russia
Status
COMPLETED
Study type
OBSERVATIONAL
Coronary Artery Disease
Start date
2022-03-03
Primary completion
2023-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.